Telesis Bio, Inc. (TBIO)

USD 0.49

(-7.55%)

Total Assets Summary of Telesis Bio, Inc.

Telesis Bio, Inc.'s latest annual total assets in 2023 was 70.41 Million USD , down -13.46% from previous year.
Telesis Bio, Inc.'s latest quarterly total assets in 2024 Q1 was 63.33 Million USD , down -10.06% from previous quarter.
Telesis Bio, Inc. reported annual total assets of 81.36 Million USD in 2022, down -30.02% from previous year.
Telesis Bio, Inc. reported annual total assets of 116.25 Million USD in 2021, up 332.78% from previous year.
Telesis Bio, Inc. reported quarterly total assets of 63.33 Million USD for 2024 Q1, down -10.06% from previous quarter.
Telesis Bio, Inc. reported quarterly total assets of 89.16 Million USD for 2023 Q1, up 9.59% from previous quarter.

Annual Total Assets Chart of Telesis Bio, Inc. (2023 - 2016)

Historical Annual Total Assets of Telesis Bio, Inc. (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	70.41 Million USD	-13.46%
2022	81.36 Million USD	-30.02%
2021	116.25 Million USD	332.78%
2020	26.86 Million USD	-30.7%
2019	38.76 Million USD	-86.52%
2018	287.65 Million USD	44.88%
2017	198.54 Million USD	-3.41%
2016	205.56 Million USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	52.72 Million USD	-16.74%
2024 Q1	63.33 Million USD	-10.06%
2023 Q1	89.16 Million USD	9.59%
2023 Q4	70.41 Million USD	-32.96%
2023 Q2	114.52 Million USD	28.45%
2023 FY	70.41 Million USD	-13.46%
2023 Q3	105.02 Million USD	-8.29%
2022 Q3	88.14 Million USD	-9.4%
2022 Q4	81.36 Million USD	-7.69%
2022 FY	81.36 Million USD	-30.02%
2022 Q1	111.13 Million USD	-4.41%
2022 Q2	97.28 Million USD	-12.46%
2021 Q3	124.49 Million USD	-8.74%
2021 Q1	31.31 Million USD	16.58%
2021 FY	116.25 Million USD	332.78%
2021 Q4	116.25 Million USD	-6.62%
2021 Q2	136.41 Million USD	335.59%
2020 Q2	454.27 Million USD	48.83%
2020 Q4	26.86 Million USD	-97.04%
2020 Q3	908.62 Million USD	100.02%
2020 Q1	305.24 Million USD	-9.21%
2020 FY	26.86 Million USD	-30.7%
2019 Q3	349.51 Million USD	15.52%
2019 Q1	277.73 Million USD	-3.45%
2019 FY	38.76 Million USD	-86.52%
2019 Q4	336.2 Million USD	-3.81%
2019 Q2	302.54 Million USD	8.93%
2018 Q1	182.83 Million USD	-7.91%
2018 FY	287.65 Million USD	44.88%
2018 Q4	287.65 Million USD	-5.56%
2018 Q3	304.58 Million USD	83.12%
2018 Q2	166.33 Million USD	-9.03%
2017 FY	198.54 Million USD	-3.41%
2017 Q4	198.54 Million USD	0.0%
2016 FY	205.56 Million USD	0.0%

Peer Total Assets Comparison of Telesis Bio, Inc.

Name	Total Assets	Total Assets Difference
Acutus Medical, Inc.	53.96 Million USD	-30.487%
Biotricity, Inc.	5.94 Million USD	-1084.847%
Cell MedX Corp.	46.12 Thousand USD	-152562.504%
Dynatronics Corporation	25.94 Million USD	-171.432%
Nemaura Medical Inc.	14.56 Million USD	-383.485%
PetVivo Holdings, Inc.	3.11 Million USD	-2160.202%
RetinalGenix Technologies Inc.	156.00 USD	-45135156.41%
Sonendo, Inc.	78.16 Million USD	9.914%
Talis Biomedical Corporation	98.34 Million USD	28.4%
Viveve Medical, Inc.	25.91 Million USD	-171.721%